Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Pfizer Strikes Deal With Array BioPharma on Anti-Cancer Development December 18, 2017 Kindred Bio To Announce Fourth Quarter And Year-End 2016 Financial Results February 20, 2017 Roivant Licenses Diabetes Drug From Ligand Pharma March 6, 2018
